Drug Profile
Research programme: topical iodine - Symbollon
Alternative Names: IoDermLatest Information Update: 12 Jan 2022
Price :
$50
*
At a glance
- Originator Symbollon Pharmaceuticals
- Class Disinfectants; Halogens
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Wounds
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Wounds in USA (Topical)
- 21 Feb 2011 Preclinical trials in Wounds in USA (Topical)